Last 12 months
Inside the activity.
1 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2025 Filed Nov 19, 2025 23:52 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-114230 · tm2526800-12_4seq1.xml · derivative · entry 4 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F3 · derivative.exercise_date: The restricted stock units were granted on September 8, 2025 and vested as to 500 shares on November 10, 2025, of which 268 shares settled for cash. The restricted stock units will vest as to the remaining shares in two equal installments on each of December 28, 2025 and June 28, 2026. F3 · derivative.expiration_date: The restricted stock units were granted on September 8, 2025 and vested as to 500 shares on November 10, 2025, of which 268 shares settled for cash. The restricted stock units will vest as to the remaining shares in two equal installments on each of December 28, 2025 and June 28, 2026. Read SEC document |
| November 10, 2025 Filed Nov 19, 2025 23:52 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-114230 · tm2526800-12_4seq1.xml · derivative · entry 3 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 1,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units were granted on August 11, 2025. Subsequent to the grant on August 11, 2025, the vesting schedule of the restricted stock units was amended to be identical to the vesting schedule of the 1,500 restricted stock units granted on September 8, 2025. Accordingly, the restricted stock units vested as to 1,200 shares on November 10, 2025, of which 642 shares settled for cash. The restricted stock units will vest as to the remaining shares in two equal installments on each of December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units were granted on August 11, 2025. Subsequent to the grant on August 11, 2025, the vesting schedule of the restricted stock units was amended to be identical to the vesting schedule of the 1,500 restricted stock units granted on September 8, 2025. Accordingly, the restricted stock units vested as to 1,200 shares on November 10, 2025, of which 642 shares settled for cash. The restricted stock units will vest as to the remaining shares in two equal installments on each of December 28, 2025 and June 28, 2026. Read SEC document |
| November 10, 2025 Filed Nov 19, 2025 23:52 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionCommon Stock | 232 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-114230 · tm2526800-12_4seq1.xml · nonDerivative · entry 2 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,604 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. Read SEC document |
| November 10, 2025 Filed Nov 19, 2025 23:52 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionCommon Stock | 558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-114230 · tm2526800-12_4seq1.xml · nonDerivative · entry 1 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 8,334 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · derivative · entry 6 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,334 shares Expires 2028-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in three equal annual installments, beginning June 29, 2024. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · derivative · entry 5 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
SaleCommon Stock | 4,775 | $14.88 | $71,068.24 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · nonDerivative · entry 4 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,964 F2 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $14.85 to $14.915. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
Exercise / conversionCommon Stock | 8,334 | $7.10 | $59,171.40 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · nonDerivative · entry 3 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
SaleCommon Stock | 6,428 | $14.89 | $95,703.28 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · nonDerivative · entry 2 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,405 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $14.85 to $15.025. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 23:00 UTC |
Brissenden Richard W.Director
|
Exercise / conversionCommon Stock | 7,500 | $1.25 | $9,375.00 |
DisclosureSEC source: 0001104659-25-093034 · tm2526903-2_4seq1.xml · nonDerivative · entry 1 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 22:58 UTC |
Chan JeffreyVP - Finance
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,333 | $0.00 Strike: $7.10 | $0.00 |
DisclosureSEC source: 0001104659-25-093033 · tm2526903-1_4seq1.xml · derivative · entry 3 Chan Jeffrey · CIK 0002012198 · VP - Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock · 13,333 shares Expires 2028-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in three equal annual installments, beginning June 29, 2024. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 22:58 UTC |
Chan JeffreyVP - Finance
|
SaleCommon Stock | 13,333 | $14.89 | $198,525.70 |
DisclosureSEC source: 0001104659-25-093033 · tm2526903-1_4seq1.xml · nonDerivative · entry 2 Chan Jeffrey · CIK 0002012198 · VP - Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,267 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $14.59 to $15.103. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 22:58 UTC |
Chan JeffreyVP - Finance
|
Exercise / conversionCommon Stock | 13,333 | $7.10 | $94,664.30 |
DisclosureSEC source: 0001104659-25-093033 · tm2526903-1_4seq1.xml · nonDerivative · entry 1 Chan Jeffrey · CIK 0002012198 · VP - Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:58 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
Exercise / conversionStock Option (right to buy) · Derivative | 210,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-092635 · tm2526800-3_4seq1.xml · derivative · entry 5 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 210,000 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:58 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
SaleCommon Stock | 21,000 | $14.34 | $301,236.60 |
DisclosureSEC source: 0001104659-25-092635 · tm2526800-3_4seq1.xml · nonDerivative · entry 2 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,096 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $13.71 to $14.6579. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:58 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
Exercise / conversionCommon Stock | 210,000 | $1.25 | $262,500.00 |
DisclosureSEC source: 0001104659-25-092635 · tm2526800-3_4seq1.xml · nonDerivative · entry 1 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:56 UTC |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-092634 · tm2526800-4_4seq1.xml · derivative · entry 5 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:56 UTC |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
SaleCommon Stock | 50,000 | $14.35 | $717,335.00 |
DisclosureSEC source: 0001104659-25-092634 · tm2526800-4_4seq1.xml · nonDerivative · entry 2 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 F1 · price: The price reported in Column 4 is a weighted average price. Mr. McEwen sold shares in multiple transactions at prices ranging from $13.69 to $14.6625. Mr. McEwen undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2025 Filed Sep 23, 2025 23:56 UTC |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
Exercise / conversionCommon Stock | 500,000 | $1.25 | $625,000.00 |
DisclosureSEC source: 0001104659-25-092634 · tm2526800-4_4seq1.xml · nonDerivative · entry 1 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:31 UTC Amendment |
Diges Carmen LGeneral Counsel/Corp Sec
|
Exercise / conversionStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-094523 · tm2527112-2_4aseq1.xml · derivative · entry 3 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,000 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:31 UTC Amendment |
Diges Carmen LGeneral Counsel/Corp Sec
|
SaleCommon Stock | 21,000 | $14.34 | $301,236.60 |
DisclosureSEC source: 0001104659-25-094523 · tm2527112-2_4aseq1.xml · nonDerivative · entry 2 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,096 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $13.71 to $14.6579. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:31 UTC Amendment |
Diges Carmen LGeneral Counsel/Corp Sec
|
Exercise / conversionCommon Stock | 21,000 | $1.25 | $26,250.00 |
DisclosureSEC source: 0001104659-25-094523 · tm2527112-2_4aseq1.xml · nonDerivative · entry 1 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:30 UTC Amendment |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-094516 · tm2527112-1_4aseq1.xml · derivative · entry 3 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:30 UTC Amendment |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
SaleCommon Stock | 50,000 | $14.35 | $717,335.00 |
DisclosureSEC source: 0001104659-25-094516 · tm2527112-1_4aseq1.xml · nonDerivative · entry 2 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. Mr. McEwen sold shares in multiple transactions at prices ranging from $13.69 to $14.6625. Mr. McEwen undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2025 Filed Sep 29, 2025 20:30 UTC Amendment |
McEwen Robert RossDirector · Chairman and CEO · 10% owner
|
Exercise / conversionCommon Stock | 50,000 | $1.25 | $62,500.00 |
DisclosureSEC source: 0001104659-25-094516 · tm2527112-1_4aseq1.xml · nonDerivative · entry 1 McEwen Robert Ross · CIK 0001316599 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2025 Filed Nov 19, 2025 23:50 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,600 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001104659-25-114229 · tm2526800-2_4seq1.xml · derivative · entry 3 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,600 shares Expires 2025-09-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in three equal annual installments, beginning September 29, 2021. Read SEC document |
| September 19, 2025 Filed Nov 19, 2025 23:50 UTC |
Spears Stephan MichaelVP Corporate Development
|
SaleCommon Stock | 12,600 | $14.35 | $180,781.02 |
DisclosureSEC source: 0001104659-25-114229 · tm2526800-2_4seq1.xml · nonDerivative · entry 2 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,814 F1 · price: The price reported in Column 4 is a weighted average price. The Reporting Person sold shares in multiple transactions at prices ranging from $13.71 to $14.65. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 19, 2025 Filed Nov 19, 2025 23:50 UTC |
Spears Stephan MichaelVP Corporate Development
|
Exercise / conversionCommon Stock | 12,600 | $1.25 | $15,750.00 |
DisclosureSEC source: 0001104659-25-114229 · tm2526800-2_4seq1.xml · nonDerivative · entry 1 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2025 Filed Sep 11, 2025 00:03 UTC |
Kaszas Stephen DouglasDirector
|
GrantDeferred Stock Units · Derivative | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089177 · tm2525795-8_4seq1.xml · derivative · entry 1 Kaszas Stephen Douglas · CIK 0002074277 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726 Underlying: Common Stock · 726 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. F2 · derivative.expiration_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. Read SEC document |
| September 08, 2025 Filed Sep 11, 2025 00:02 UTC |
Asterbadi Dalia NadineDirector
|
GrantDeferred Stock Units · Derivative | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089176 · tm2525795-7_4seq1.xml · derivative · entry 1 Asterbadi Dalia Nadine · CIK 0002074268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726 Underlying: Common Stock · 726 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. F2 · derivative.expiration_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. Read SEC document |
| September 08, 2025 Filed Sep 11, 2025 00:00 UTC |
Florek John CasimirDirector
|
GrantDeferred Stock Units · Derivative | 726 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089174 · tm2525795-6_4seq1.xml · derivative · entry 1 Florek John Casimir · CIK 0002074273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726 Underlying: Common Stock · 726 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents a right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. F2 · derivative.expiration_date: The deferred stock units are fully vested and will be delivered to the reporting person on the date of the reporting person's termination of continuous service from the Issuer's Board of Directors (the "Board"), subject to the reporting person's right to elect to defer delivery of the deferred stock units beyond the date of the reporting person's termination of continuous service from the Board. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 22:14 UTC |
Shaver William MDirector · Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089149 · tm2525795-5_4seq1.xml · derivative · entry 1 Shaver William M · CIK 0001887702 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 22:13 UTC |
Ing PerryChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089148 · tm2525795-4_4seq1.xml · derivative · entry 1 Ing Perry · CIK 0001429244 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 2,400 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 22:11 UTC |
Spears Stephan MichaelVP Corporate Development
|
GrantRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089147 · tm2525795-3_4seq1.xml · derivative · entry 1 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units will vest in three equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units will vest in three equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 22:10 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
GrantRestricted Stock Units · Derivative | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089146 · tm2525795-2_4seq1.xml · derivative · entry 1 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 22:09 UTC |
Chan JeffreyVP - Finance
|
GrantRestricted Stock Units · Derivative | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-089145 · tm2525795-1_4seq1.xml · derivative · entry 1 Chan Jeffrey · CIK 0002012198 · VP - Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F2 · derivative.exercise_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. F2 · derivative.expiration_date: The restricted stock units will vest in three approximately equal installments on each of November 10, 2025, December 28, 2025 and June 28, 2026. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:52 UTC |
Ball Ian JDirector
|
SaleCommon Stock | 2,656 | $10.49 | $27,861.44 |
DisclosureSEC source: 0001104659-25-078784 · tm2523562-1_4seq1.xml · nonDerivative · entry 1 Ball Ian J · CIK 0001443094 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Canadian RRSP Account Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. The reporting person sold shares in multiple transactions at prices ranging from C$14.44 to C$14.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F2 · price: Converted from Canadian weighted average purchase price per share of C$14.4456 using an exchange rate of C$1.00 = US$0.7260, as reported by the Bank of Canada on August 12, 2025. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:27 UTC |
Spears Stephan MichaelVP Corporate Development
|
GrantRestricted Stock Units · Derivative | 3,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-077757 · tm2523410-8_4seq1.xml · derivative · entry 2 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,600 Underlying: Common Stock · 3,600 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:27 UTC |
Spears Stephan MichaelVP Corporate Development
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077757 · tm2523410-8_4seq1.xml · derivative · entry 1 Spears Stephan Michael · CIK 0001443450 · VP Corporate Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:26 UTC |
Brissenden Richard W.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077756 · tm2523410-7_4seq1.xml · derivative · entry 1 Brissenden Richard W. · CIK 0001540320 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:26 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
GrantRestricted Stock Units · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-077755 · tm2523410-15_4seq1.xml · derivative · entry 2 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 3,900 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:26 UTC |
Diges Carmen LGeneral Counsel/Corp Sec
|
GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077755 · tm2523410-15_4seq1.xml · derivative · entry 1 Diges Carmen L · CIK 0001651496 · General Counsel/Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:25 UTC |
Melanson Michael NelsonDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077754 · tm2523410-6_4seq1.xml · derivative · entry 1 Melanson Michael Nelson · CIK 0002074279 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:25 UTC |
Asterbadi Dalia NadineDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077753 · tm2523410-14_4seq1.xml · derivative · entry 1 Asterbadi Dalia Nadine · CIK 0002074268 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:24 UTC |
Shaver William MDirector · Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 6,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-077751 · tm2523410-13_4seq1.xml · derivative · entry 2 Shaver William M · CIK 0001887702 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,300 Underlying: Common Stock · 6,300 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F3 · derivative.exercise_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. F3 · derivative.expiration_date: The restricted stock units will vest in three equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:24 UTC |
Shaver William MDirector · Chief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077751 · tm2523410-13_4seq1.xml · derivative · entry 1 Shaver William M · CIK 0001887702 · Director · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:23 UTC |
Florek John CasimirDirector
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077748 · tm2523410-12_4seq1.xml · derivative · entry 1 Florek John Casimir · CIK 0002074273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:22 UTC |
Darveau-Garneau NicolasDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077747 · tm2523410-5_4seq1.xml · derivative · entry 1 Darveau-Garneau Nicolas · CIK 0002002294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:22 UTC |
Ing PerryChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-077745 · tm2523410-11_4seq1.xml · derivative · entry 2 Ing Perry · CIK 0001429244 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,600 Underlying: Common Stock · 5,600 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock, or the cash value thereof as set forth in the award agreement, in the discretion of the Issuer's Compensation, Nominating & Corporate Governance Committee. F3 · derivative.exercise_date: The restricted stock units will vest in three approximately equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. F3 · derivative.expiration_date: The restricted stock units will vest in three approximately equal installments on each of December 29, 2025, June 29, 2026 and December 29, 2026. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 23:22 UTC |
Ing PerryChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $10.43 | $0.00 |
DisclosureSEC source: 0001104659-25-077745 · tm2523410-11_4seq1.xml · derivative · entry 1 Ing Perry · CIK 0001429244 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-11 F1 · derivative.exercise_date: The option vests in three equal annual installments, beginning August 11, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.